David H. Drewry

6.0k citations

102 papers · 2.5k indexed · h-index 29

Impact in

Computational Theory and Mathematics top 1%
- Computational Drug Discovery Methods
Organic Chemistry top 5%
- Click Chemistry and Applications

Papers in

Cell Biology 18
- Microtubule and mitosis dynamics 11
Computational Theory and Mathematics 15
- Computational Drug Discovery Methods 15

Co-authors: William J. Zuercher Ricardo Macarrón Carrow I. Wells Timothy M. Willson Steve F. Poon Diane M. Coe Andrew B. McElroy Alison D. Axtman
Journals: Journal of Medicinal Chemistry (13 papers)Scientific Reports (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Molecules (4 papers)ACS Medicinal Chemistry Letters (4 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

David H. Drewry

95 papers receiving 2.4k citations

Peers

Countries citing papers authored by David H. Drewry

Since Specialization

Citations

This map shows the geographic impact of David H. Drewry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Drewry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Drewry more than expected).

Fields of papers citing papers by David H. Drewry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Drewry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Drewry. The network helps show where David H. Drewry may publish in the future.

Co-authors

The 25 scholars most cited alongside David H. Drewry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David H. Drewry Line = papers co-authored together David H. Drewry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy Nature Communications ·J.A. Newman, A.E. Gavard, Nergis Imprachim, H. Aitkenhead, Hadley E. Sheppard, Robert te Poele, Paul A. Clarke, Mohammad Anwar Hossain, Louisa Temme, Hans J. Oh, Carrow I. Wells, Zachary W. Davis‐Gilbert, Paul Workman, O. Gileadi, David H. Drewry	2025	2
2	More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5- a ]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication Journal of Medicinal Chemistry ·Han Wee Ong, Xuan Yang, Jeffery L. Smith, Rebekah J. Dickmander, Jason W. Brown, Tammy M. Havener, Sharon Taft-Benz, Stefanie Howell, Marcia K. Sanders, Jacob L. Capener, Rafael M. Couñago, Edcon Chang, Andreas Krämer, Nathaniel J. Moorman, Mark T. Heise, Alison D. Axtman, David H. Drewry, Timothy M. Willson	2024	6
3	Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2 Molecules ·Han Wee Ong, Xuan Yang, Jeffery L. Smith, Sharon Taft-Benz, Stefanie Howell, Rebekah J. Dickmander, Tammy M. Havener, Marcia K. Sanders, Jason W. Brown, Rafael M. Couñago, Edcon Chang, Andreas Krämer, Nathaniel J. Moorman, Mark T. Heise, Alison D. Axtman, David H. Drewry, Timothy M. Willson	2024	1
4	Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In Vitro Cancers ·Jiung Nam, Amelia U. Schirmer, Chelsea Loh, David H. Drewry, Everardo Macias	2023	2
5	Characterization of 2,4-Dianilinopyrimidines Against Five P. falciparum Kinases PfARK1, PfARK3, PfNEK3, PfPK9, and PfPKB ACS Medicinal Chemistry Letters ·Han Wee Ong, Chandi de Silva, Krisha Avalani, Frank E. Kwarcinski, Christopher R. Mansfield, Michael E. Chirgwin, Anna Truong, Emily R. Derbyshire, Reena Zutshi, David H. Drewry	2023	3
6	Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective ACS Chemical Neuroscience ·Han Wee Ong, Yi Liang, William Richardson, Emily R. Lowry, Carrow I. Wells, Xiangrong Chen, Margaux Silvestre, Kelvin Dempster, Josie A. Silvaroli, Jeffery L. Smith, Hynek Wichterle, Navjotsingh Pabla, Sila K. Ultanir, Alex N. Bullock, David H. Drewry, Alison D. Axtman	2023	7
7	How many kinases are druggable? A review of our current understanding Biochemical Journal ·Brian Anderson, Peter Rosston, Han Wee Ong, Mohammad Anwar Hossain, Zachary W. Davis‐Gilbert, David H. Drewry	2023	20
8	Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology eLife ·Anna Castano, Margaux Silvestre, Carrow I. Wells, Jennifer L. Sanderson, Carla A. Ferrer, Han Wee Ong, Lang Yi, William Richardson, Josie A. Silvaroli, Frances M. Bashore, Jeffery L. Smith, Isabelle M Genereux, Kelvin Dempster, David H. Drewry, Navlot S Pabla, Alex N. Bullock, Tim A. Benke, Sila K. Ultanir, Alison D. Axtman	2023	11
9	A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi Nature Communications ·Thaila Fernanda dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, Camila Figueiredo Pinzan, Pedro Filho Noronha Souza, Suzanne Ackloo, Mohammad Anwar Hossain, David H. Drewry, Sondus Alkhazraji, Ashraf S. Ibrahim, Hyunil Jo, Jorge D. Lightfoot, Emily M. Adams, Kevin K. Fuller, William F. DeGrado, Gustavo H. Goldman	2023	40
10	An open source plant kinase chemogenomics set Plant Direct ·María Florencia Ercoli, Priscila Zonzini Ramos, Rashmi Jain, Joseph Pilotte, Oliver Xiaoou Dong, Ty Thompson, Carrow I. Wells, Jonathan M. Elkins, A.M. Edwards, Rafael M. Couñago, David H. Drewry, Pamela C. Ronald	2022	1
11	Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer Molecular Therapy ·Amelia U. Schirmer, Lucy M. Driver, Megan T. Zhao, Carrow I. Wells, Julie E. Pickett, Sean N. O’Bryne, Benjamin J. Eduful, Xuan Yang, Lauren E. Howard, Sungyong You, Gayathri R. Devi, John DiGiovanni, Stephen J. Freedland, Jen‐Tsan Chi, David H. Drewry, Everardo Macias	2021	23
12	Host-directed therapy, an untapped opportunity for antimalarial intervention Cell Reports Medicine ·Ling Wei, Jack Adderley, Didier Leroy, David H. Drewry, Danny W. Wilson, Alexis Kaushansky, Christian Doerig	2021	30
13	Quantifying CDK inhibitor selectivity in live cells Nature Communications ·Carrow I. Wells, James D. Vasta, Cesear Corona, Jennifer Wilkinson, Chad Zimprich, Morgan R. Ingold, Julie E. Pickett, David H. Drewry, Kathryn Pugh, Marie K. Schwinn, Byounghoon Hwang, Hicham Zegzouti, K. Huber, Mei Cong, Poncho Meisenheimer, Timothy M. Willson, Matthew B. Robers	2020	78
14	Binding and structural analyses of potent inhibitors of the human Ca2+/calmodulin dependent protein kinase kinase 2 (CAMKK2) identified from a collection of commercially-available kinase inhibitors Scientific Reports ·Gerson S. Profeta, C.V. dos Reis, André da Silva Santiago, Paulo H. Godoi, M. Angela, Carrow I. Wells, Roger Sartori, Anita Salmazo, Priscila Zonzini Ramos, Katlin B. Massirer, Jonathan M. Elkins, David H. Drewry, O. Gileadi, Rafael M. Couñago	2019	15
15	SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K ACS Medicinal Chemistry Letters ·Carrow I. Wells, Rafael M. Couñago, Juanita C. Limas, Tuanny L. Almeida, Jeanette Gowen Cook, David H. Drewry, Jonathan M. Elkins, O. Gileadi, Nirav Kapadia, Álvaro Lorente‐Macías, Julie E. Pickett, Alexander J. Riemen, Roberta R. Ruela-de-Sousa, Timothy M. Willson, Cunyu Zhang, William J. Zuercher, Reena Zutshi, Alison D. Axtman	2019	28
16	New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors Biochemical Journal ·Dominic P. Byrne, Yong Li, Pawin Ngamlert, Krithika Ramakrishnan, Claire E. Eyers, Carrow I. Wells, David H. Drewry, William J. Zuercher, Neil G. Berry, David G. Fernig, Patrick A. Eyers	2018	28
17	GW779439X and Its Pyrazolopyridazine Derivatives Inhibit the Serine/Threonine Kinase Stk1 and Act As Antibiotic Adjuvants against β-Lactam-Resistant Staphylococcus aureus ACS Infectious Diseases ·Adam J. Schaenzer, Nathan Wlodarchak, David H. Drewry, William J. Zuercher, Warren E. Rose, Carla A. Ferrer, John‐Demian Sauer, Rob Striker	2018	26
18	In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth Molecular Pharmaceutics ·Nathan Wlodarchak, Nathan Teachout, Jeffrey Beczkiewicz, Rebecca R. Procknow, Adam J. Schaenzer, Kenneth A. Satyshur, Martin S. Pavelka, William J. Zuercher, David H. Drewry, John‐Demian Sauer, Rob Striker	2018	22
19	Enhancements of screening collections to address areas of unmet medical need: an industry perspective Current Opinion in Chemical Biology ·David H. Drewry, Ricardo Macarrón	2010	112
20	Array synthesis of progesterone receptor antagonists: 3-Aryl-1,2-diazepines Bioorganic & Medicinal Chemistry Letters ·Robert W. Wiethe, Eugene L. Stewart, David H. Drewry, David W. Gray, Abdul Mehbob, William J. Hoekstra	2006	14

About David H. Drewry

David H. Drewry is a scholar working on Cell Biology, Computational Theory and Mathematics, Molecular Biology, Organic Chemistry and Oncology, having authored 102 papers that have together received 2.5k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (15 papers), Cancer-related Molecular Pathways (12 papers), Chemical Synthesis and Analysis (11 papers), Microtubule and mitosis dynamics (11 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Click Chemistry and Applications (8 papers), Quinazolinone synthesis and applications (5 papers) and Melanoma and MAPK Pathways (5 papers). The work is most often cited by research in Computational Theory and Mathematics (392 citations), Organic Chemistry (612 citations), Molecular Biology (1.4k citations), Cancer Research (308 citations) and Oncology (507 citations). David H. Drewry has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include William J. Zuercher, Ricardo Macarrón, Carrow I. Wells, Timothy M. Willson, Steve F. Poon, Diane M. Coe, Andrew B. McElroy, Alison D. Axtman, Millard H. Lambert and Gavin Harper. Their work appears in journals such as Journal of Medicinal Chemistry, Scientific Reports, Bioorganic & Medicinal Chemistry Letters, Molecules and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact